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• We showcase the health equity 
impact plane with two worked 
examples.
• The health equity impact 
plane shows health impact and 
equity impact (reduction in 
health inequalities) for one or 
more policies.
• This can help clarify potential 
trade-offs between improving 
health and reducing health 
inequality.
Summary
This briefing introduces the 
health equity impact plane – a 
simple visual tool for clarifying 
the relationship between cost-
effectiveness (total health 
impact) and equity impact 
(health inequality reduction). 
The equity impact plane can be 
used to compare policy options 
based on these two key policy 
objectives. It can also be used 
to clarify thinking about policy 
trade-offs and compromises, and 
to re-design policies to reduce 
health inequality in cost-effective 
ways that do not sacrifice large 
potential health gains.
Introduction
Decision makers want to 
choose programmes that are 
good value for money. That is 
why organisations like the UK 
National Institute for Health and 
Care Excellence (NICE) consider 
costs as well as health benefits. 
If an intervention costs a lot but 
only increases population health 
a little, then the resources may 
be better spent elsewhere to 
gain more health for the same 
expenditure. But the objective 
of health spending is not only 
to improve health. Policy 
makers also want to reduce 
unfair health inequalities. In 
England, for example, there was 
a gap in healthy life expectancy 
between the most and least 
deprived neighbourhoods of 
19 years in 2014-16 according 
to Public Health England.1 
Reducing health inequalities 
of this kind is enshrined in 
the NHS Constitution and in 
NICE’s equality objectives. This 
policy brief focuses on health 
inequalities associated with 
socioeconomic position (i.e. 
between rich and poor), but 
the health equity impact plane 
can also be used to analyse 
health inequality itself or health 
inequalities by geographical 
location, gender, race, ethnicity, 
and other equity-relevant 
variables. The Marmot Review 
(2010)2 endorsed the idea of 
‘proportionate universalism’ – 
providing universal services in 
proportion to what is needed 
for a long and healthy life. The 
equity impact plane can help 
put that idea into practice, by 
analysing how much additional 
resource is worth investing in 
proportion to needs.
Is our programme a win-win?
When compared to current 
practice, the introduction of 
many cost-effective health 
interventions will reduce health 
inequalities as well as increasing 
total health; they are ‘win-win’ 
programmes. However, some 
cost-effective interventions like 
bowel cancer screening increase 
total health but increase health 
inequalities, because socially 
disadvantaged people do not 
participate as much; they are 
a ‘win-lose’. Conversely, some 
interventions may be cost-
ineffective but reduce health 
inequalities; they are a ‘lose-
win’. For example, treatment for 
mesothelioma costs upwards 
of £50,000 per healthy year 
gained. This is more than the 
typical NICE benchmark of 
value for money. Provision of 
mesothelioma treatment would 
divert money from treatments 
that can deliver larger health 
gains for the same expenditure 
– the health opportunity cost 
exceeds the health benefits. 
However, treating mesothelioma 
reduces health inequality 
through improving the health 
of disadvantaged people who 
worked in traditional industries 
with asbestos. Finally, some cost-
ineffective interventions not 
only harm total health – because 
they divert expenditure from 
more beneficial uses – but also 
increase health inequalities; a 
‘lose-lose’.
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Figure 1. Health Equity Impact Plane
If we have a portfolio of health 
interventions to consider for a 
health system, it might make 
sense to mainly include ‘win-win’ 
interventions, but also some ‘win-
lose’ and ‘lose-win’ interventions, 
depending on the priority given 
to reducing health inequalities 
compared with increasing total 
health. So, for example, a local 
public health team may face 
a choice between spending 
more money on breastfeeding 
peer support – a ‘win-lose’ 
intervention which may be used 
more by affluent mothers and 
therefore increase inequalities 
– versus targeted screening for 
abdominal aortic aneurysm – a 
‘lose-win’ intervention which may 
cost more per case detected than 
universal screening but reduce 
health inequalities by increasing 
uptake in deprived areas. 
Interventions may be re-designed 
in response to inequalities so, for 
example, targeting might change 
cardiovascular screening from 
being a ‘win-lose’ to a ‘win-win’.
We can display the cost 
effectiveness or total health 
benefit of an intervention 
together with its impact on 
equity on a health equity impact 
plane (Figure 1). We focus on 
'net' health benefits, allowing 
for health opportunity costs – 
the health forgone by diverting 
money from other uses – as 
well as health benefits. Equity 
impact is a summary measure 
of health inequality reduction, 
such as change in a slope index 
of inequality (SII), allowing for 
differences in health opportunity 
cost by social group. Where 
interventions lie in the 'win-
lose' or 'lose-win' quadrants, 
then compromises are needed 
between total health benefit and 
inequality reduction.
Ethical issues
Some people may think it is 
unethical to talk about equity 
'trade-offs', as reducing health 
inequality may seem too 
important to trade against other 
policy objectives. However, 
other policy objectives may 
also be ethically compelling. For 
example, breast cancer affects 
rich, elderly people more than 
poor, young people.3 So reducing 
health inequality militates against 
investing in costly new breast 
cancer services that divert money 
from services for poorer, younger 
people. Yet no-one would 
advocate withdrawing money 
completely from breast cancer 
services. Rather than talking 
about 'trade-offs', the language 
of 'compromise' may seem more 
appropriate. The same applies 
to ethical arguments about 
cost-effectiveness analysis in 
general. Some people think that 
you can never put a price on life 
and health. However, resources 
are scarce and priority-setting 
decisions inevitable; it is better 
that compromises between 
competing priorities are made in 
a transparent, accountable way.
Worked Example 1
In this example we look at 
two hypothetical options for 
public funding of NRT (nicotine 
replacement therapy) to help 
people quit smoking, compared 
with no public funding (‘no NRT’). 
The ‘universal’ scenario is offering 
NRT to the whole population, 
while the ‘proportionate 
universal’ is having NRT targeted 
more to deprived areas with 
higher smoking rates. Figure 
2 shows net health benefit on 
the vertical (y) axis. This allows 
for the health opportunity cost 
of spending money on NRT, in 
terms of reduced spending on 
other public health services that 
would have delivered health 
benefits. Each £8,000 spent on 
other public health services 
is estimated to produce the 
equivalent of one year of full 
health (a quality adjusted life 
year or QALY), based on the 
estimated median marginal 
production cost of health for 
all public health interventions 
modelled for NICE in England 
from 2011-2016.4 The equity 
impact is shown on the horizontal 
(x) axis, measured in terms of 
a slope index of inequality (SII) 
showing the modelled health gap 
between most and least deprived 
neighbourhoods, allowing for 
the gradient in between. In this 
example, both the ‘universal’ 
and the ‘proportionate universal’ 
scenarios are ‘win-win’ when 
compared a baseline scenario of 
no NRT – they increase health 
and reduce health inequality. 
But the ‘proportionate universal’ 
scenario has a bigger impact 
on reducing inequalities, at the 
expense of a smaller total health 
impact. So the decision maker 
has to consider the importance 
of improving total health versus 
reducing health inequalities. For 
the ‘proportionate universal’ 
intervention, the equity impact 
is a reduction in the population 
SII of about 0.6 ten thousandths 
and the loss in total health is 
about 1,000 QALYs, compared 
with the ‘universal’ scenario. 
(Figure 2). Methods are available 
to help policy makers assess the 
size and importance of different 
reductions in health inequality, by 
systematically equity-weighting 
health benefits using an equity 
parameter that represents the 
degree of priority given to people 
with worse health, but that takes 
us beyond the scope of this short 
policy briefing.5
Figure 2. Health equity impact plane: Net health benefits (QALYs gained) and SII for two 
smoking cessation scenarios ('Universal', and 'Proportionate Universal').  
Note: based on £8,000 per QALY health production costs.
Worked Example 2
In this example we look at 
three hypothetical scenarios for 
cardiovascular screening – known 
as 'NHS Health Checks' – that 
were compared to a scenario 
of no screening. The ‘current’ 
scenario modelled current Health 
Checks performance in Liverpool, 
while for ‘increased’ we assumed 
that uptake increased from 32% 
to 66%, and for ‘targeted’ we 
assumed that uptake increased 
to 66% in the most deprived 
IMD fifth only. Because this is 
a healthcare service with costs 
falling on other healthcare 
treatments, rather than a public 
health service, we estimate health 
opportunity costs using a value 
of £13,000 per QALY produced, 
based on the estimated marginal 
production cost of health in the 
English NHS.6 We again used a 
reduction in the slope index of 
inequality as the equity impact 
measure. This study found that 
only the ‘targeted’ scenario was 
in the ‘win-win’ quadrant of the 
health equity impact plane. The 
‘increased’ scenario was very 
close to zero in terms of both net 
health benefit and equity benefit, 
while the ‘current’ scenario had 
a negative net health benefit as 
well as a negative equity benefit, 
so it was a ‘lose-lose’ (Figure 3, 
overleaf).
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Figure 3. Health equity impact plane: Net health benefits (QALYs gained per 100,000 
person years) and change in SII in incremental net health benefits per 100,000 person 
years for three Health Check scenarios (current, increased, targeted) compared with 
“No Health Checks”. Modelled data for Liverpool, 2011-2040.  
Note: based on £13,000 per QALY health production costs. 
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